Information Technology · Services-Business Services, NEC

HQY HEALTHEQUITY, INC. SEC Filings & Insider Trading Activity 2026

company
CIK 1428336120 filings
Russell 2000

HQY at a glance

HEALTHEQUITY, INC. (HQY, SEC CIK 1428336) filed its latest 10-K annual report on March 17, 2026, a 10-Q quarterly report on August 27, 2026, an 8-K current report on October 9, 2026 and Form 4 insider filings as recently as October 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended January 31, 2026 (FY2026), HEALTHEQUITY, INC. (HQY) reported revenue of $1.3 billion (up 9.5% from FY2025) and net income of $215.2 million. Diluted EPS was $2.46.
  • As of September 30, 2026, 38 institutional investment managers tracked by SignalX reported holding HEALTHEQUITY, INC. (HQY) shares worth $3.4 billion in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Rajasekar Sunil on October 15, 2026 of 108 shares at $90.33 per share.
  • In the last 90 days, HQY insiders reported 1 open-market purchase ($10K) and 3 open-market sales ($810K) on Form 4, a net sale of $800K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$1.3B
+9.5% vs prior year
Insiders · 90 days
1 buy · 3 sells
Net −$800K
13F holders
38 funds
$3.4B · +1 vs prior quarter
Latest 8-K
Oct 9, 2026
Item 5.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Jan 31, 2026

Full analysis →

Business Overview

  • Core business: Technology-enabled administration of tax-advantaged health savings accounts (HSAs) and complementary consumer-directed benefits (CDBs) for employers
  • New acquisition: BenefitWallet HSA portfolio with 616,000 HSAs and $2.7 billion in assets acquired for $425 million in fiscal 2025
  • Strategic focus: Increased AI integration for customer service, process efficiency, and platform modernization to enhance member experience and scalability
  • Quantitative metric: Administered 10.6 million HSAs and 7.2 million complementary CDBs totaling 17.8 million accounts as of January 31, 2026
  • Notable fact: Increased HSA market share to 20% by June 2025, largest by number of accounts and second largest by assets per Devenir report

Risk Factors

  • Regulatory risk: Compliance with July 2025 "One Big Beautiful Bill Act" expanding HSA availability to Bronze and Catastrophic plans with uncertain impact on business
  • Macroeconomic risk: Interest rate fluctuations affect custodial revenue; uses Treasury bond forwards to hedge but still exposed to prevailing government-driven rates
  • Operational risk: Integration and efficient consolidation of acquired HSA portfolios critical for growth from competitors divesting non-core HSA businesses
  • Competitive risk: Competition from Fidelity Investments, UnitedHealth Group's Optum, and Webster Bank with greater resources for product development and support
  • Financial risk: Variable interest expense on Revolving Credit Facility due to changes in prevailing interest rates impacting cost structure

Management Discussion & Analysis

  • Cash and cash equivalents $318.9M as of Jan 31, 2026, up from $295.9M as of Jan 31, 2025
  • Liquidity sources include cash balances, custodial/service/interchange collections, Revolving Credit Facility availability
  • Revolving Credit Facility up to $1.0B matures Aug 23, 2029, for working capital, acquisitions, and general corporate purposes
  • No revenue, profitability, or segment performance data provided in the MD&A section

AI summary of the HQY 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Jul 31, 2026

Management Discussion & Analysis

  • HSAs 10.739M, up 8% YoY; CDBs 7.016M, down 2% YoY
  • Total HSA Assets $37.921B, up 14% YoY; HSA investments $20.552B, up 28%
  • Client-held funds $931M, up 14% YoY; average quarter-to-date balance $936M, up 6%
  • Outlook: continued HSA growth opportunities alongside interest-rate, tax-policy, regulatory, and competitive risks

Risk Factors

  • No material changes to 10-K risk factors for fiscal year ended January 31, 2026
  • Carried-forward risks could materially adversely affect business, financial condition, and results
  • Unidentified or currently immaterial risks could affect operations unexpectedly
  • No newly triggered regulatory, legal, operational, competitive, or financial risk disclosed

AI summary of the HQY 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 9, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Chief Commercial Officer Michael Fiore terminated without cause, effective October 5, 2026
  • Commercial leadership responsibilities redistributed across existing management, indicating no immediate replacement
Filed Sep 30, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Noémie Heuland appointed director, expanding Board to 11 members from 10
  • Moody’s CFO joins Audit and Risk Committee and Cybersecurity and Technology Committee

Item 7.01: Regulation FD Disclosure

  • Press release announces Ms. Heuland’s appointment to the HealthEquity board
  • Board expansion or refreshment may affect governance, oversight and strategic direction
Filed Aug 27, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 FY2027 revenue $350.7M, up 8%, with custodial revenue $175.9M as the largest stream
  • GAAP net income $65.6M, up 10%, while diluted EPS rose 15% to $0.78

Item 2.02: Results of Operations and Financial Condition

  • HealthEquity furnished an August 27, 2026 press release covering fiscal-year 2026 results
  • Detailed financial results and management commentary are in Exhibit 99.1

AI summaries of HQY 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for HQY

Don't miss the next HQY filing

  • Alerts as it files. A push when HQY files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut HQY, by share count.
  • Ask anything. An AI agent that reads every HQY filing and answers with sources.

HQY alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Rajasekar SunilBuyOct 15, 2026$90.33
Gathright MichaelFOct 6, 2026$91.16
Ladd DelanoFOct 6, 2026$91.16
Lucania James MFOct 6, 2026$91.16
Fiore Michael HenryFOct 6, 2026$91.16
Cutler ScottFOct 6, 2026$91.16
Neeleman StephenFOct 6, 2026$91.16
Neeleman StephenGSep 17, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$1.2B$1.3B
Gross Profit-$777.3M$913.1M
Operating Income-$162.3M$322.5M
Net Income-$96.7M$215.2M
Gross Margin-64.8%69.5%
Op. Margin-13.5%24.6%
Net Margin-8.1%16.4%
Balance Sheet
Total Assets$3.2B$3.4B$3.4B
Equity$2.0B$2.1B$2.1B
ROE-4.6%10.2%
Per Share
EPS-$1.09$2.46
Cash Flow
Operating CF-$339.9M$457.1M
CapEx-$2.1M$2.0M

Source: XBRL data in HEALTHEQUITY, INC. (HQY)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate HQY share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
HQY shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202638$3.39B
Q2 202637$3.70B
Q1 202636$3.17B
Q4 202532$3.61B
Q3 202533$4.17B
Q2 202533$4.58B
Q1 202530$2.80B
Q4 202424$2.66B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 263 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

HQY filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Oct 19, 2026--
8-KOct 9, 2026Analysis-
4Oct 8, 2026--
4Oct 8, 2026--
4Oct 8, 2026--
4Oct 8, 2026--
4Oct 8, 2026--
4Oct 8, 2026--
8-KSep 30, 2026Analysis-
4Sep 18, 2026--
4Aug 27, 2026--
8-KAug 27, 2026Analysis-
10-QAug 27, 2026Analysis
4Jul 14, 2026--
4Jul 13, 2026--
4Jul 10, 2026--
4Jul 10, 2026--
4Jul 10, 2026--
4Jul 10, 2026--
4Jul 10, 2026--
4Jul 7, 2026--
4Jun 29, 2026--
4Jun 29, 2026--
4Jun 29, 2026--
4Jun 29, 2026--

Related Information Technology companies

All Information Technology →

HQY SEC filings: frequently asked questions

Are HQY insiders buying or selling?

In the last 90 days, HEALTHEQUITY, INC. (HQY) officers, directors and 10% owners reported 1 open-market purchase worth $9,756 by 1 insider and 3 open-market sales worth $809,778 by 2 insiders on Form 4, a net sale of $800,022. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold HQY stock?

As of September 30, 2026, the largest HEALTHEQUITY, INC. (HQY) holders among the 13F filers tracked by SignalX were BlackRock ($999.7 million), Vanguard Portfolio Management LLC ($349.6 million), Morgan Stanley ($336.7 million), Vanguard Capital Management LLC ($316.2 million), State Street Corp ($286.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was HQY's revenue in fiscal year 2026?

For the fiscal year ended January 31, 2026 (FY2026), HEALTHEQUITY, INC. (HQY) reported revenue of $1.3 billion (up 9.5% from FY2025) and net income of $215.2 million. Diluted EPS was $2.46. The figures come from the XBRL data in the 10-K.

What are the main risks in HQY's latest 10-K?

In the 10-K filed March 17, 2026, HEALTHEQUITY, INC. (HQY) flagged: Regulatory risk: Compliance with July 2025 "One Big Beautiful Bill Act" expanding HSA availability to Bronze and Catastrophic plans with uncertain impact on business. Macroeconomic risk: Interest rate fluctuations affect custodial revenue; uses Treasury bond forwards to hedge but still exposed to prevailing government-driven rates. (AI summary of the Risk Factors section.)

What did HQY report in its latest 8-K?

HEALTHEQUITY, INC. (HQY) filed an 8-K on October 9, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). Chief Commercial Officer Michael Fiore terminated without cause, effective October 5, 2026.

What are the latest HQY SEC filings?

HEALTHEQUITY, INC. (HQY) filed its latest 10-K annual report on March 17, 2026, a 10-Q quarterly report on August 27, 2026, an 8-K current report on October 9, 2026 and a Form 4 insider filing on October 19, 2026.

What is HQY's SEC CIK number?

HEALTHEQUITY, INC. (HQY)'s SEC Central Index Key (CIK) is 1428336. EDGAR lists every HQY filing under that number.

Ask anything about HQY

The research agent reads HQY's filings, financials, insider trades and 13F holders, then answers with sources.